425: Strive, Semler Scientific Pursue Business Combination

Strive, Inc. and Semler Scientific, Inc. are pursuing a proposed business combination, as disclosed in a recent communication.

Summary

• Strive, Inc. is pursuing a proposed business combination with Semler Scientific, Inc.
• The communication regarding this proposed transaction was posted on X.com by Arshia Sarkhani, Chief Marketing Officer of Strive, Inc., on September 22, 2025.
• The filing includes extensive cautionary statements regarding forward-looking statements related to the transaction, highlighting inherent risks and uncertainties.
• Strive intends to file a Registration Statement on Form S-4 with the SEC to register Class A common stock to be issued in connection with the proposed transaction.
• The Registration Statement will include an Information Statement of Strive, a Proxy Statement of Semler Scientific, and a Prospectus of Strive, which will be sent to Semler Scientific stockholders for approval.

Sentiment

Score: 5

Explanation: The filing is a neutral legal disclosure about a proposed merger, heavily focused on cautionary statements and risks rather than positive or negative performance. The extensive risk factors balance any inherent positivity of a merger announcement.

Positives

• The proposed transaction is expected to yield strategic benefits and financial benefits for the combined company.
• Anticipated cost savings and strategic gains are expected from the successful integration of the businesses.

Risks

• The occurrence of any event, change, or circumstances that could give rise to the right of one or both companies to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all due to conditions not being received or satisfied on a timely basis.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• The possibility that anticipated benefits, including cost savings and strategic gains, are not realized when expected or at all.
• Risks associated with changes in, or problems arising from, implementation of Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement could negatively impact the transaction.
• The integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated due to unexpected factors or events.
• Diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships resulting from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before closing.

Future Outlook

The filing discusses forward-looking statements related to the outlook and expectations of Strive and Semler Scientific concerning the proposed transaction, including strategic and financial benefits, impact on future financial performance, timing of closing, and integration success. However, it does not provide specific future outlook or guidance, focusing instead on the inherent risks and uncertainties associated with such statements.

Management Comments

• Arshia Sarkhani, Chief Marketing Officer of Strive, Inc., posted a communication on X.com on September 22, 2025, in connection with Strive's proposed business combination with Semler Scientific, Inc.

Industry Context

The filing highlights the potential for companies to adopt 'Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets,' indicating a broader trend of integrating digital asset management into corporate financial strategies, which is notable given Semler Scientific's primary business in medical devices.

Stakeholder Impact

• Shareholders of Strive will experience dilution due to the issuance of additional Class A common stock.
• Shareholders of Semler Scientific will be asked to approve the proposed transaction.
• Customers and employees of both Strive and Semler Scientific may experience potential adverse reactions or changes to business or employee relationships as a result of the announcement or completion of the proposed transaction.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to the stockholders of Semler Scientific to seek their approval of the proposed transaction.
• Investors and stockholders are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus when they become available.

Key Dates

Keywords

Strive Inc., Semler Scientific Inc., Merger, Business Combination, SEC Filing, Form 425, Corporate Governance, Financial Reporting, Bitcoin Treasury Strategy